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Most strains of type III pneumococcus possess a particularly high virulence 
for man (1) once infection has become established. Recent study of this organ- 
ism in relation to phagocytosis (2) has revealed that strains of maximum viru- 
lence exhibit during logarithmic growth,  a  wide capsular "slime layer" which 
interferes with surface phagocytosis. The sfime layer can be visualized by elec- 
tronic  microscopy and  stains  metachromatically with  methylene  blue.  The 
metachromasia is due  to  the presence in  the  slime layer of viscous  type III 
polysaccharide, a  high molecular polymer of 4-~-glucuronosidoglucose  (3).  In 
broth cultures the capsular slime layer is lost with  aging of the bacterial pop- 
ulation,  and pneumococcus III is then,  like other encapsulated bacteria,  sus- 
ceptib|e to surface phagocytosis. 
Recovery from acute bacterial pneumonia has been shown to depend in part 
upon surface phagocytosis, a  defense reaction of the host that operates in the 
absence of specific antibodies  (4-6).  Since virulent  strains  of type  III pneu- 
mococci in the logarithmic phase of growth are resistant to this form of phago- 
cytosis,  experiments have  been performed  to  determine  the influence  of  the 
slime layer upon the in  ~vo behavior of pneumococcus III. Systematic study 
of induced pulmonary infection has revealed certain host-parasite relationships 
that appear to account for the relative malignancy of type III pneumonia. 
Characteristics  of Pneumonic Lesion Caused  by Highly  Virulent Strain  of 
Type  III  Pneumococcus 
Fatality Rate and Survival Time.--Experimental  pneumonia was produced in albino rats by 
the method previously described (7). A strain of type III pneumoeoccus (8HCC), the cap- 
sular properties of which have been determined by in vitro studies (2), was grown for 4 hours 
in serum-beef infusion broth  (2), suspended in mucin, and inoculated intrabronchially. The 
number of organisms introduced into the left main bronchus varied from 500 to 5000. The 
resulting pneumonia was uniformly fatal, all of 72 untreated rats dying within 96 hours after 
inoculation. Although 14 of the infected animals failed to survive for 24 hours, the great 
majority (46) died on the 2nd day of the infection. The mean survival time was shorter than 
that observed in comparable experiments with type I pneumococcus (Text-fig. 1). 
* This study was supported by the Commonweatlh Fund. 
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Gross Pathology.--All rats dying of untreated type III pneumonia exhibited 
both pIeurisy and pericarditis. The pleurisy was usually fibrinous and was ac- 
companied by a cloudy effusion which more often than not was bilateral. Simi- 
lar changes were noted in the pericardial cavity. In animals surviving for more 
than 36 hours the exudate was thick and gelatinous. 
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TmxT-FtG. 1. Comparative  survival times of rats dying of type I and type III pneumonias. 
The progress of the pneumonic lesion in the left lobe was studied by sacrificing 
animals at various stages of the infection as shown in Text-fig. 2. It will be noted 
that the lesion continued to spread until most of the lobe was involved at the 
end of 36 hours. 
In its gross appearance the pneumonic lesion caused by type III pneumo- 
coccus simulated that of experimental type I pneumonia (7) with one important 
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showed  evidence of  abscess  formation  similar  to  that  seen  in  Friedl~inder's 
pneumonia (8). 
Histopathology.--Details of the  histopathology of experimental pneumonia 
caused by type I pneumococcus and Friedl~nder's bacillus have been published 
elsewhere (7, 8). The same techniques of fixing the lungs and of sectioning and 
staining the tissues (Gram-Weigert stain) were used in the present experiments. 
Animals  were sacrificed for study at  the intervals designated in  Text-fig. 2. 
Microscopic findings were, with the exceptions mentioned below, identical with 
those of experimental type I pneumonia. The same edema zone was noted at the 
margins of the spreading lesions (Fig. 1). In the more central area of consolida- 
tion phagocytosis by polymorphonuclear leucocytes was  prominent  (Fig.  2). 
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TExT-FIG.  2. Extent of pulmonary lesion and incidence  of bacteriemia at various stages of 
experimental type III pneumonia. 
*  Based on autopsy findings in 3 rats sacrificed  at each interval. 
Clearing was seen in some of the older parts of the lesions and was characterized 
by the presence of macrophages (Fig. 3). 
Three histologic features, not present in type I  pneumonia, were prominent 
in the type III lesions. First, as already stated, areas of frank abscess formation 
were frequently noted after 36 hours  (Fig. 4).  The pneumococci seen in  the 
necrotic exudate of these abscesses were often pleomorphic and poorly stained, 
indicating local bacteriostasis. Secondly, the number of pneumococci per alveo- 
lus in certain parts of the lesions was far greater than that ever observed in type 
I  infections (Fig. 5). In these most heavily infected areas there was often little 
or no phagocytosis, and necrosis of leucocytes and cells of the alveolar walls 
was noted, suggesting the early stages of an abscess. Thirdly, a coarse reticular 
precipitate was visible in certain of the infected edema-filled alveoli at the pe- 
riphery of the lesion (Fig. 6). Evidence is presented in the next section that this 88  HOST-PARASrrE  RELATIONSHIPS  IN  PNEUMONIA 
reticular  precipitate  contained  excess  capsular  polysaccharide synthesized  by 
the growing pneumococci. 
Relation  of Capsular  Polysaccharide  to Itistologic  Features  of Lesion 
Method  of Study.--The capsular  polysaccharide,  when present  either  in  the 
wide  slime  layer  of  type  III pneumococcus  or  in  the  surrounding  medium, 
stains metachromatically with methylene blue. Treatment  with chemical fixa- 
tives, such as Zenker's solution, formalin, or alcohol so alters the high molecular 
polysaccharide as to prevent the metachromasia. In order to study the capsular 
carbohydrate  in  lung  sections,  therefore,  it  is  necessary  to  avoid  the  use  of 
chemical fixatives in preparing the tissue for staining with methylene blue. The 
following method was found to be satisfactory for this purpose. 
At necropsy the aorta was clamped while the heart was still beating; the pulmonary vessels 
were tied off with a single ligature (7), and the lungs were sufficiently reinflated with air to 
fill the thoracic cage. When the trachea  had been ligated, the lungs were removed from the 
thorax, wrapped in filter paper, and frozen immediately in the dry ice box. The frozen tissues 
were cut on a rotary microtome in the cold room (0-5°C.), the knife blade  being "frozen" 
with CO2 gas just prior to the sectioning of each block. The sections cut at a thickness of 5 
micra were transferred  immediately  to clean glass slides where they were allowed to dry. 
They were then  stained  for 1 minute  with  alkaline methylene  blue  (2), washed with tap 
water, dried, and mounted in balsam. 
To supplement this frozen section technique impression smears were made of representa- 
tive fresh lesions and were likewise air-dried and stained with methylene blue. Such smears 
contained leucocytes, bacteria, and tissue fluid from the alveolar exudate, but in contrast  to 
the frozen sections they did not depict the general architecture of the pneumonic process and 
contained extraneous red blood cells derived from pulmonary vessels transected in the cutting 
of the fresh tissue. 
The Capsular  Slime Layer and Phagocflosis.--The  capsular  slime  layer  of 
type  III pneumococcus  renders  the  organism  relatively  resistant  to  surface 
phagocytosis in vitro (2). The effect of this outer capsular structure irl vivo was 
determined by study of frozen sections and impression smears of lesions from 
animals sacrificed 6,  18, 30, and 48 hours after inoculation. For the most part 
only organisms  that  had  lost  their  metachromatic  slime  layers,  presumably 
through aging of the local bacterial population, were phagocyted by the poly- 
morphonuclear leucocytes. The partially denuded organisms were most numer- 
ous  in  the  older,  more heavily consolidated  parts  of the  lesion.  Most  of the 
pneumococci that had not been phagocyted and were located in the more re- 
cently developed peripheral portions of the lesion still exhibited the wide outer 
capsular layer  (Fig. 8).  Intermediate  areas often contained pneumococci both 
with and without slime layers, and in these alveoli the preferential phagocytosis 
of the denuded organisms was particularly striking  (Fig. 9).  As in the in vitro 
experiments  some  intracellular  slime-covered  pneumococci  were  occasionally W.  BARRY  WOOD~ JR.,  AND  MARY  RUTH  SMITH  89 
found, particularly in macrophages,  but  this finding was the exception rather 
than the rule3 
Polysaccharide  in  the  Alveolar  Exudate.--Free  capsular  substance,  which 
stained  metachromatically,  was visible in the alveolar exudate  of many parts 
of the more advanced pneumonic lesions.  The metachromaticaUy stained ma- 
terial in the exudate was shown to contain capsular polysaccharide by the fact 
that its characteristic staining properties were destroyed by pretreatment of the 
impression  smears  with  homologous type-specific antiserum  (2).  Addition  of 
heterologous antiserum to the smears prior to application of the methylene blue 
stain had no effect upon the metachromasia.  Although the free capsular sub- 
stance usually appeared  as a  pink-staining,  amorphous precipitate  in the exu- 
date  (Fig.  10),  it sometimes formed a  reticular matrix  (Fig.  11).  Some of the 
organisms visible in the precipitate had prominent capsular slime layers, where- 
as others, having lost this outer capsular structure,  exhibited no stainable cap- 
sule at all. Intermediate forms that appeared only partially denuded were also 
present. 
The metachromatic capsular substance in the exudate  was most concentrated 
in those areas in which bacterial growth  was maximum. Since early necrosis of 
leucocytes and other tissue ceils was also evident in these same regions of maxi- 
mum infection,  the  question  arose as  to whether  the  free capsular  substance 
might not be cytotoxic and thus contribute to abscess formation. 
Possible Leucocidal Action of Type III Polysaccharide.--Accordingly in vitro 
phagocytic tests on filter paper using pneumococcus type I  (4) were carried out 
in the presence of an excess of capsular material derived both from serum-broth 
cultures and from infected pleural fluid.  2 The presence  of the capsular carbo- 
hydrate  in  the  test  mixtures  was  easily identified  by:  (a)  its  metachromatie 
staining properties and (b) its precipitation by type III antiserum. No evidence 
could be obtained  that  the polysaccharide affected  the  leucocytes sufficiently 
to interfere  with  surface phagocytosis. Likewise phagocytosis of encapsulated 
l In unpublished in vitro experiments high concentrations  (5 to 50 per cent) of normal rat 
serum, containing no demonstrable type-specific opsonins, have been found to increase slightly 
the susceptibility of slime-covered type III pneumococci to surface phagocytosis. This obser- 
vation may account in part for the phagocytosis  of slime-covered organisms occasionally 
noted in vivo in the apparent absence of specific antibody. 
When serum-broth  cultures were used for the source of excess polysaccharide, the cul- 
tures  were incubated  for 24 to 48 hours and the bacteria  were removed by centrifugation. 
Pleural fluid of high polysaccharide content was obtained from rats inoculated intrapleurally 
with approximately  20 type III pneumococci and treated  18 hours  after inoculation  with 
3000 units of procaine penicillin (duracillin).  Treatment was administered  intramuscularly 
every 12 hours, and the animals were sacrificed at the end of 3 days. When the thorax was 
opened, 0.2 ml. of liquaemin (Roche Organon, Inc.) was added to the pleural fluid to prevent 
clotting, and the fluid, which was shown by culture  to contain no viable pneumococci, was 
centrifuged for 30 minutes at 3000 R.I,.M. The final supernatant contained large amounts  of 
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test  organisms  (type  I  pneumococcus)  took place  as  usual  when  leucocyte- 
bacterial mixtures were incubated on the cut surfaces of type III lesions con- 
taining large amounts of polysaccharide.  In addition,  fluid from cultures and 
pleural exudates of high polysaccharide concentration were injected both intra- 
bronchiaUy and subcutaneously to determine the effect of the capsular carbo- 
hydrate  upon  normal  tissues.  No  signs  of necrotoxicity were  noted  in  the 
histologic  sections  from any of  the  test  animals.  It  is  concluded,  therefore, 
that type III polysaccharide, in the form in which it exists in the animal body, 
does not injure significantly either leucocytes or other tissue cells. 
Growth and Survival  of  Type  III  Pneumococcus in  Pneumonic  Lesion 
As already stated, histologic study of type III pneumonia revealed an exces- 
sive number of organisms in some parts of the lesion. Also, in these areas of 
maximum bacterial growth there was relatively little phagocytosis, most of the 
extracellular  organisms  having  prominent  slime  layers.  Because  of  the  pre- 
viously demonstrated  resistance  of  the  slime-covered type  III organisms  to 
surface phagocytosis (2), it seemed likely that pneumococcus III might survive 
more  readily  in  the  alveolar  exudate  than  pneumococcus  I  and  thus  might 
produce  a  more heavily infected lesion. The number of viable organisms per 
gram of consolidated lung was therefore determined at various stages  of both 
type  I  and  type  III pneumonia.  The method  used  to  obtain  these  "in dvo 
growth curves" was as follows:-- 
Three rats with each of the two types of pneumonia were killed 6, 18, 30, and 48 hours 
after inoculation. The thorax was opened aseptically and the infected left lung was removed 
and placed in a sterile Petri dish. From a representative portion of the consolidated lesion a 
wedge-shaped sample was cut, weighed, and ground with sterile sand in a mortar. The ground 
tissue was diluted 1 to 10 with tryptose phosphate broth and bacterial counts were then made 
in the usual manner. 
As shown in Text-fig. 3, there were, in all but the earliest lesions, more than 
ten times as many viable pneumococci per gram of tissue in the type III infec- 
tions as in those caused by pneumococcus I. Although the method of quantita- 
fion used was admittedly crude, the mean differences noted in the two infections 
were found to be statistically significant.  3 
Response  to Chemotherapy 
Rats with both type III and type I pneumonia were treated with sulfadlazine 
according to the method previously described (9). 300 rag. of sulfadiazine was 
given by stomach tube 6 hours after inoculation,  12 hours later, and every 24 
8 The statistical analyses were kindly performed by Dr. Robert Shank of the Department 
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of Preventive Medicine. The ratios of the  for the four points on 
Standard error of difference 
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hours thereafter throughout the period of observation. The effect of the drug 
upon the type III infection  4 was similar to that previously reported in type I 
pneumonia  (10).  Spread of the lesion stopped within  18 hours after the start 
of treatment. Serial histologic studies revealed the same prominent phagocytic 
reaction noted in the type I  infection. The one important difference observed 
in the type III animals was the frequent occurrence of abscesses in lesions that 
otherwise appeared to be responding favorably to the chemotherapy. Nearly 
all the lungs examined after the first day of infection had definite abscesses, and 
multiple areas of suppuration were common particularly in the older lesions. 
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TEXT-FIo. 3.  Bacterial counts in the pulmonary lesions of experimental type I and type 
III pneumonias. 
By the 5th day the abscesses were beginning to be walled off by fibroblastic 
proliferation in the alveoli adjacent to the dense leucocytic barrier which sur- 
rounded the necrotic core of the abscess (Fig. 7). The central zone was charac- 
terized by ischemia, the presence of fibrin, and relatively few phagocytic cells, 
most of which  were in varying stages of disintegration.  Pleomorphic bacteria 
were visible in small numbers within  the necrotic exudate.  When  cultured  at 
4  When pneumococcus HI is incubated in beef infusion broth  (pH 7.8) containing 1 per 
cent rabbit serum and 10 per cent suLfadiazine, a ropy sediment of relatively small volume 
containing chains of pneumococci entangled in a fibrous precipitate of polysaccharide forms 
at the bottom of the tube. The sediment is in marked contrast to the smooth viscous cen- 
trifugate of large volume obtained from cultures grown in the plain broth. This finding sug- 
gests that sulfadiazine disturbs the synthesis of type III polysaccharide, either through bac- 
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the end of 2 weeks abscesses were found still to contain viable type III pneumo- 
cocci despite  a full week's treatment with sulfadiazine. 
Similar experiments  were also done  with penicillin, and a detailed account 
of the results will be  published elsewhere (11). Penicillin acted more promptly 
than sulfadiazine on both the type III and the type I  lesions, but again phago- 
cytosis was prominent in the alveolar exudate and appeared  to be responsible 
for the  destruction of many of the organisms.  In contrast to the findings in 
type I pneumonia, most of the type III lesions contained abscesses in spite of the 
chemotherapy. Prolonged treatment with penicillin (2 weeks) failed to rid the 
abscesses of pneumococci. Estimation of the number of viable organisms in the 
infected lungs of animals treated with penicillin showed that the destruction of 
bacteria in the type III lesions was not only less complete (i.e. lung abscesses) 
but also significantly less prompt than in the type I pneumonia,  in spite of the 
fact that the two organisms were equally sensitive to penicillin in vitro. 
Process  of Resolution 
Resolution of the pneumonic exudate in the non-suppurating portions of the 
lesion involved not only the destruction of bacteria and clearing of the exudate 
but also the removal  of the large amounts of capsular  polysaccharide  which 
had accumulated in the alveoli. The latter process was found to be relatively 
slow, there being specific carbohydrate demonstrable  in the lesion more than 
2 weeks after inoculation.  Serial histologic studies revealed  that some of the 
polysaccharide  was carried  away by lymphatic drainage  (Fig.12) to regional 
lymph nodes. The rest was phagocyted in the alveoli, particularly by macro- 
phages (Fig. 13), which likewise appeared to be removed from the lesion ~/a the 
peritruncal lymphatics.  The  fact  that the  polysaccharide  antigen could  be 
identified by its metachromatic staining within the cytoplasm of phagocytic 
cells suggests  that it had not combined  with specific antibody before being 
phagocyted (2). 
Pathogenesis  of Abscess  Formation 
Since type III pneumococeus, in contrast to type I, was found to produce 
lung abscesses with surprising  regularity, experiments were designed to ascer- 
tain, ff possible, the factors responsible for the pulmonary suppuration. Type I 
pneumococcus, when inoculated intrabronchially with mucin in doses of 1000 
to 5000, uniformly produces fatal lobar pneumonia,  but at no stage of the in- 
fection do excessive numbers of extracellular bacteria accumulate in the lesion, 
and suppuration rarely occurs either in untreated animals  (7)  or in those re- 
ceiving penicilfin after 18 hours (11).  s It was found, however, that if the intra- 
5 Suppuration, apparently caused by the irritative action of the mucin, may occur at the 
original site of inoculation. In the present study only those abscesses dearly located outside 
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bronchial inoculum is increased to 500,000 or more, the bacterial  multiplication 
is so rapid during the early stages of the infection that the cellular defenses of 
the  lung are overwhelmed,  and  a  dense population of extracellular  organisms 
accumulates in the infected alveoli. By intensive penicillin therapy  6 begun after 
18 hours,  such malignant infections can be controlled,  but examination  of the 
lungs after 5 days invariably reveals extensive abscess formation. 
Thus,  under  the  proper  conditions,  type I  pneumococcus will produce  the 
same  form of pulmonary  suppuration  as  that  caused  by maximally  virulent 
strains  of pneumococcus  III. The  type  I  organisms  must  be  injected  intra- 
bronchially in large numbers in order to attain a  sufficient population density 
in the lesion to cause necrosis. A  relatively small inoculum (100 organisms)  of 
maximally virulent  type III pneumococci, on the other hand,  will ultimately 
cause the same result.  The greater tendency of type III pneumococci of max/- 
mum virulence to produce lung abscesses appears,  therefore,  to be due, not to 
the presence of excessive amounts of free polysaccharide, but to the fact that 
the  capsular  slime layer interferes  with surface phagocytosis  (2)  and  thereby 
permits  the  accumulation  of  a  sufficiently  large  extracellular  population  of 
bacteria to cause tissue necrosis. 
Selective Destruction in  Vivo of Intermediate Mutant 
Evidence has already been presented  that phagocytic cells in the lung pref- 
erentially phagocyte those type III pneumococci which possess no slime layer. 
The efficiency with which such organisms are destroyed in the lung as compared 
to those with intact slime layers is conclusively demonstrated by the following 
experiment. 
Each of 45 rats was inoculated intrabronchially  with 4000 to 6000 intermediate  type III 
pneumococci suspended in 0.1 ml. of 6 per cent mucin  (7). The intermediate  mutant em- 
ployed was that derived from the 8HCC strain  of pneumococcus III in this laboratory (2). 
Although considerably less virulent  than the parent strain,  the intermediate  mutant caused 
31 of the 45 rats to die within 1 week of inoculation. At postmortem examination the lesions 
were extensive, and all but 3 animals  (which died during  the first 2 days) showed multiple 
areas  of suppuration.  Impression smears of the late  lesions, when stained  with  methylene 
blue,  revealed  many slime-covered pneumococci' and  much excess polysaccharide  in  the 
alveolar exudate. Blood cultures  taken at the time of death were positive, but the organism 
present was invariably the mucoid parent strain  rather than the intermediate. Only in animals 
dying within the first 48 hours was the intermediate strain  isolated from the blood. Two rats 
that died at 24 and 25 hours respectively had both intermediate and mucoid organisms in the 
blood at the time of death. A third  animal had intermediates in the blood on day 1, negative 
blood cultures on days 2 and 3, and a  terminal  bacteriemia due to the mucoid  parent on 
day 4. 
6  6000 units of procaine penicillin in oil (duracillin) injected intramuscularly  6 hours after 
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These  observations  suggest that the intermediate strain underwent a back- 
mutation in vivo, the reversion rate having been sufficient to produce in the end 
a pneumonia due to the maximally virulent parent.  Since backmutation was 
observed neither on repeated plating of intermediate cultures nor during peri- 
toneal infections in mice, it was concluded that reversion to the parent form 
was brought about primarily by selective destruction of the easily phagocyted 
intermediate organisms by the highly efficient phagocytic mechanism operating 
in the lung (4, 5). This conclusion was substantiated by histologic study of serial 
lesions by the methylene blue technique. Whereas only intermediate organisms 
were found during the earliest stages of the infection, the pneumococci demon- 
strable in the older lesions were predominantly of the mucoid type. The transi- 
tion from intermediate to slime-covered pneumococci could be seen to result 
from the preferential  phagocytosis  of organisms lacking the slime layer.  The 
failure  of  reversion  to  take  place  during peritoneal  infections  in  mice  was 
thought to be  due to the relative  inefficiency of the phagocytic mechanism 
operating in the peritoneal cavity (4). 
Similar experiments were carried out with a transformed intermediate strain 
originally obtained by growing a rough variant of type II pneumococcus in the 
presence of transforming substance  extracted from an intermediate mutant of 
type III (12). The stock cultures used for intrabronchial  inoculation were made 
from single cell preparations  of the transformed intermediate strain.  7 Although 
somewhat more stable than naturally occurring intermediate mutants (13), the 
transformed strain likewise changed  to  the mucoid  form in  the pneumonic 
exudate and ultimately caused a fatal infection. The mucoid organisms were 
shown to be derived from the parent intermediate strain by the fact that they 
possessed the specific protein antigen (14) of the original type II pneumococ- 
cus.  s This reversion, occurring in a bacterial population originally derived from 
a single intermediate cell, clearly indicates the occurrence of a backmutation. 
DISCUSSION 
The relative malignancy of experimental  pneumonia produced with a maxi- 
mally virulent type III pneumococcus is indicated by the comparatively short 
survival time of rats infected with the 8HCC strain of pneumococcus III and 
by the high incidence of multiple lung abscesses complicating  the infection. 
Both of these findings are in keeping with clinical observations relating to type 
III pneumonia.  Case fatality rates in untreated lobar pneumonia of pneumo- 
coccal etiology are usually higher in type III cases than in those of any other 
7 Kindly supplied by Dr. Colin MacLeod and Dr. Robert Austrian, Department of Micro- 
biology, New York University College of Medicine. 
a The tests for type-specific protein antigen were done by Dr. Austrian. W.  BARRY  WOOD,  ~'R.,  AND  MARY  RUTH  SMITH  95 
type (1), 9 and only in type HI pneumococcal infections  does pulmonary sup- 
puration often occur (15, 17). 
Maximally  virulent  strains  of pneumococcus III,  during  the  logarithmic 
phase of growth,  produce excessive  amounts  of capsular polysaccharide and 
possess on their capsular surfaces a wide slime layer containing loosely packed 
macromolecules  of type-specific  carbohydrate (2). During the course of experi- 
mental  pneumonia,  the  excess  polysaccharide  resulting  from  growth  of  the 
organism accumulates in large  quantities within the infected alveoli,  bronchi, 
and pleural fluid.  Similar  deposits of capsular carbohydrate are demonstrable 
in the lungs  of patients dying of type III pneumonia (17, 18) (Fig.  14): Since 
the long-chained  glucose-glucuronic  acid polymers of type III  carbohydrate 
are highly asymmetrical molecules, and since they cause liquid media in which 
they are dispersed  to be of high viscosity (19), it is assumed that the charac- 
teristic viscous consistency of type III exudates is due to the presence of free 
polysaccharide. Likewise,  the sputum from patients with type III pneumonia 
is often of a  jelly-like consistency and  contains  large  quantities  of capsular 
carbohydrate (20) which forms a  characteristic reticulum  (21). 
It might be assumed that the presence of such large amounts of type-specific 
carbohydrate in the lesion would interfere with recovery of the host, either by 
damaging phagocytic or other cells in the lung or by neutralizing type-specific 
antibody. No evidence was obtained in the present study that  type III poly- 
saccharide  is either leucocidal  or of sufficient  toxicity to tissue cells to cause 
necrosis. 1° Its possible neutralization of antibody would appear to be of signi- 
ficance only in relatively long standing infections,  since evidence has been pre- 
sented elsewhere  that  type-specific  antibody does not play an important  role 
in recovery from experimental pneumonia until after the 3rd day of the disease 
(22).  The excess  polysaccharide which  forms the capsular  slime layer on the 
surface of the type III pneumococcal cell does, on the other hand, have a definite 
effect upon pathogenicity. Its presence interferes with surface phagocytosis in 
the  lung  and  thus  allows  the organism  to produce a  more heavily infected 
pneumonic lesion than is caused by other types of pneumococci. 
Fortunately for the host the slime layer of pneumococcus III is present only 
during the logarithmic  phase of growth  (2) and  therefore fails  to protect the 
organism against surface phagocytosis except during the earliest stages of the 
bacterial invasion.  When spread of the pneumonic process is checked by effec- 
tive chemotherapy, those pneumococci not killed outright by the antimicrobial 
9 Case  fatality rates in pneumococcal pneumonia vary  considerably in  different series, 
many of which include too few cases to be statistically significant. In the largest single series 
of type III cases reported  (1S)  the fatality rate was 60.6 per cent--a figure considerably 
higher than any encountered in pneumococcal pneumonia of other types. 
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drug ultimately  lose their slime layers and are destroyed by alveolar phagocytes. 
Only in loci of necrosis, where the majority of phagocytic cells are non-viable, 
can organisms survive indefinitely. 
In contrast to the rapid destruction of bacteria in the resolving lesion, the 
excess polysaccharide  deposited  in the alveoli can be demonstrated to persist 
in situ for many days. This finding is in keeping with Graeser's studies on ex- 
perimental canine pneumonia (23) and with the clinical observation that specific 
carbohydrate may be excreted in the urine for several weeks after recovery (24). 
Phagocytosis  of the specific polysaccharide  by macrophages  in the lung, and 
also in regional lymph nodes, raises interesting questions relating to antibody 
formation. Since type III polysaccharide will not stain metachromatically with 
methylene blue when combined with antibody, it appears  that the metachro- 
matic polysaccharide  demonstrated within the cytoplasm of phagocytic cells 
was phagocyted in the absence of antibody. What this process of phagocytosis 
has to do with the mechanism of antibody formation remains to be determined. 
The unique staining properties  of type III polysaccharide,  which are nullified 
by neutralization with antibody and therefore permit identification of the free 
antigen both inside and outside of cells, should make the type III carbohydrate 
particularly useful in the study of antibody synthesis. 
The tendency of type III pneumococcus to produce  pulmonary necrosis is 
best demonstrated in rats treated with penicillin or sulfonamide. Whereas  the 
pneumonia promptly resolves under treatment, the lung abscesses fail to re- 
spond and remain as obvious residua of the pulmonary infection. Their patho- 
genesis appears  to be related to the accumulation of large numbers of viable 
organisms in certain parts of the pneumonic lesion. The antiphagocytic effect 
of the capsular slime layer enables pneumococcus III to resist phagocytosis and 
thus to continue to multiply in the alveolar  exudate. Cultural methods have 
shown more viable pneumococci to be present in type III lesions than in type I, 
and histotogic studies reveal foci of denser bacterial population in experimental 
type III pneumonia  than are ever observed  in comparable  type I  infections. 
Only when very large inocula are used to produce type I pneumonia,  do suffi- 
cient organisms survive in the exudate to cause pulmonary suppuration. In the 
areas  of  excessive bacterial  concentration within  the  experimental  lesions, 
phagocytosis is depressed, alveolar capillaries are thrombosed,  and early signs 
of necrosis are evident.  The findings relative  to phagocytosis  are in keeping 
with the observation  that leucocytes, when exposed to large enough numbers 
of viable pneurnococci in vitro, not only fail to phagocyte the bacteria but also 
become non-motile  and undergo  lysis  (25). Products of the viable  organisms 
appear  also  to  cause  capillary thrombosis  which  leads  to  necrosis (26) and 
abscess formation. 
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differ from that caused by pneumococcus HI, since Friedlitnder's bacillus does 
not produce a  wide slime layer either in ~itro or in ~ivo (25) and therefore is 
relatively susceptible to surface phagocytosis (5). As reported previously, how- 
ever, bacilli accumulate in very large numbers in certain parts of the Fried- 
ltinder's lesion where they appear to cause vascular and cellular damage which 
eventuates in abscess formation (8). The accumulation of such large numbers 
of bacteria seems to be due to an ability of Friedl~nder's bacillus to grow rapidly 
in the pneumonic exudate rather than to any tendency of its capsule to protect 
it against surface phagocytosis. Whether the free polysaccharide which accumu- 
lates in the lesion exerts an antiphagocytic effect remains to be determined. 
It should be emphasized that the incidence of lung abscesses  in experimental 
type III pneumonia in rats is much higher than that encountered in the natural 
disease in man. Likewise, lung abscesses  can be produced experimentally with 
large inocula of type I pneumococcus, whereas pulmonary suppuration is rarely, 
if ever, demonstrable in human patients as a result of type I pneumonia. These 
differences are probably accounted for by the fact that the experimental in- 
fections, which were originally designed to be uniformly fatal (7),  are consid- 
erably more severe than those ordinarily encountered in clinical practice (15). 
Although analogies between the experimental and naturally occurring infection 
must be made with caution, it is considered significant that the same qualitative 
difference observed clinically between type I and type III pneumonia regarding 
abscess formation is demonstrable in experimental pneumonia when relatively 
small inocula are used. 
The clinical significance of intermediate mutants of type III pneumococcus 
is not known. It is conceivable that intermediate strains lacking the protective 
slime layer may occasionally cause relatively mild type III pneumonia. The 
present studies indicate, however, that intermediate mutants will, during the 
course of pneumonia, backmutate  and  ultimately predominate in the  pneu- 
monic lesion due to selective destruction of the intermediate forms by phago- 
cytic cells. This finding emphasizes the importance of the capsular slime layer 
of pneumococcus III and suggests that, once established in the human lung, 
initially mild intermediate infections may revert to serious pneumonia caused 
by type  III organisms of maximum pathogenicity. 
SUMMARY 
Experimental pneumonia was produced with a highly virulent strain of type 
III pneumococcus which synthesizes, during rapid growth, large amounts of 
capsular polysaccharide. The type III pneumonia differed from that caused by 
pneumococcus I in that (a) death occurred more promptly in the type III infec- 
tion, (b) the local pulmonary lesion became more heavily infected, and (c) frank 
suppuration  was  common even after otherwise effective chemotherapy. The 98  HOST-PARASITE  RELATIONSHIPS  IN  PNE~ONIA 
greater pathogenicity of the type III organism was shown by special histologic 
techniques to be due primarily to its capsular slime layer which interferes with 
surface phagocytosis. Capsular polysaccharide shed from the organism during 
growth was also demonstrated in high concentration in certain parts  of the 
pneumonic lesion.  Removal of the excess  polysaccharide from the alveoli re- 
sulted from (a)  lymphatic drainage to regional lymph nodes and  (b)  phago- 
cytosis,  particularly by macrophages.  The  possible  relationship  of  the  free 
carbohydrate to the malignancy and the characteristically viscous exudate of 
type III pneumonia was discussed. 
The lung abscesses  which resulted from type III infection were observed to 
occur in those areas in which the maximum number of organisms had accumu- 
lated.  Evidence  was  obtained  that  suppuration  was  due,  not  to  necrotoxic 
products peculiar to the type III pneumococcus, but rather to the survival of 
large numbers of bacteria in the tissues, brought about primarily by the anti- 
phagocytic effect of the slime layer. 
When pneumonia was produced with an intermediate type III mutant lack- 
ing the protective slime layer, back mutation to the mucoid parent occurred 
during the course of the infection, and the mucoid form eventually predomi- 
nated in the lung as a  result of selective phagocytosis of the intermediate or- 
ganisms. Similar mutation to the maximally virulent type III form was noted 
with a  transformed intermediate type III strain grown from single cell prep- 
arations. 
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EXPLANATION OF PLATES 
Photomicrographs made by Cramer Lewis, Department of Illustration, Washing- 
ton University School of Medicine. 
PLATE 3 
Sections stained by Gram-Weigert technique. 
FIG. 1.  Infected edema fluid in alveoli at periphery of spreading lesion. Rat sacri- 
riced 30 hours after inoculation with pneumococcus type III. X  900. 
FIG. 2.  Phagocytosis of  type  III pneumococci in  consolidated  portion  of  same 
lesion.  ×  1500 
FIG. 3.  Macrophage reaction in central portion of lesion where resolution has al- 
ready begun.  X  1500. 
FIG. 4.  Abscess formation in resolving type III lesion of rat treated for 78 hours 
with penicillin.  Animal was infected 18 hours before start of therapy.  ×  2.5. 
FIG. 5.  Accumulation of a  great number of pneumococci within a  localized area of 
the lesion depicted in Figs. 1, 2, and 3.  X  1500. 
FIG. 6.  Reticular  precipitate  contained within  some of the alveoli in the edema 
zone of the same lesion.  X  1000. 
FIG. 7.  Fibroblastic  proliferation  in alveoli surrounding  necrotic core of abscess 
caused by type III pneumococcus. Rat treated with penicillin  and sacrificed on day 5. 
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Slides stained with methylene blue. 
FIG. 8.  Failure of leucocytes in zone of early consolidation to phagocyte type III 
pneumococci possessing wide, metachromaticaUy stained slime layer. Rat sacrificed 
at 18 hours. Impression smear,  X  1500. 
FIG. 9,  Selective phagocytosis of type III pneumococci lacking wide slime layer. 
Photograph shows leucocytes from more central zone of lesion where consolidation is 
further  advanced.  Pneumococci  with  wide  slime layer have  resisted phagocytosis. 
Impression smear,  X  1500. 
FIG. 10.  Amorphous precipitate of free capsular polysaccharide in alveolar exudate 
of 50 hour lesion. Pneumococci both with and without visible slime layers are present 
in the precipitate. Impression smear,  X  1500. 
FIG. 11.  Reticular precipitation of free polysaccharide in lesion from rat sacrificed 
at 48  hours. Note pneumococci with broad, metachromatically stained slime layers 
within meshes of reticulum. Impression smear,  X  1500. 
FIG. 12.  Free polysaccharide within peritruncal lymphatic adjacent to bronchial 
wall. Rat sacrificed 120 hours after inoculation. Frozen section,  X  1500. 
FIG. 13.  Macrophages  laden  with  phagocyted  capsular  polysaccharide.  Animal 
treated with penicillin and sacrificed after 72 hours. Note large amount of free poly- 
saccharide still present in alveoli. Impression smear,  X  1170. 
FIG. 14.  Capsular polysaccharide in pneumonic lesion of 58 year old man who died 
on the 3rd day of a type III pneumococcal pneumonia. Impression smear,  X  1150. THE  JOURNAL  OF  EXPERIkIENTAL  ~EDICINE  VOL. 92  PLATE  4 
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